---
title: Cambrex vs Flamma
slug_a: cambrex
slug_b: flammagroup
site: cdmo
review_signal_gate: closed
canonical_path: /compare/cambrex/flammagroup
generated_by: BioBM Editorial AI
---

# Cambrex vs Flamma

This comparison is auto-generated by BioBM Editorial AI and intended as an evidence-oriented side-by-side reference.

## Company A

Cambrex (cambrex) is listed for cdmo. CDMO offering drug substance and drug product development, manufacturing, and analytical services across small molecules, peptides, and specialty chemistries.

Services: 15. Modalities: 2. Indications: 0. Locations: 21. Certifications: 0. Directory-wide review aggregates for this site are withheld until the review signal gate opens. The strongest documented coverage currently appears in locations (21).

Review summary: Review summary withheld until site-level review gate opens.

## Company B

Flamma (flammagroup) is listed for cdmo. Privately held small molecule CDMO with FDA-inspected cGMP facilities in Italy, USA, and China, offering custom manufacturing, development, and specialized technologies including HPAPI, continuous flow, and cryogenic API synthesis from early-stage to commercial scale.

Services: 9. Modalities: 1. Indications: 0. Locations: 7. Certifications: 1. Directory-wide review aggregates for this site are withheld until the review signal gate opens. The strongest documented coverage currently appears in services (9).

Review summary: Review summary withheld until site-level review gate opens.